Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

YTHDF1 links hypoxia adaptation and non-small cell lung cancer progression
Yulin Shi, Songqing Fan, Mengge Wu, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 298

Showing 1-25 of 298 citing articles:

The role of m6A modification in the biological functions and diseases
Xiulin Jiang, Baiyang Liu, Zhi Nie, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 1244
m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer
Huilin Huang, Hengyou Weng, Jianjun Chen
Cancer Cell (2020) Vol. 37, Iss. 3, pp. 270-288
Open Access | Times Cited: 889
The m6A reader YTHDF1 promotes ovarian cancer progression via augmenting EIF3C translation
Tao Liu, Qinglv Wei, Jing Jin, et al.
Nucleic Acids Research (2020) Vol. 48, Iss. 7, pp. 3816-3831
Open Access | Times Cited: 556
Histone lactylation drives oncogenesis by facilitating m6A reader protein YTHDF2 expression in ocular melanoma
Jie Yu, Peiwei Chai, Minyue Xie, et al.
Genome biology (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 430
The role of m6A RNA methylation in cancer metabolism
Yuanyuan An, Hua Duan
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 417
HIF-1α-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation
Qing Li, Yong Ni, Liren Zhang, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 261
m6A modification: recent advances, anticancer targeted drug discovery and beyond
Lijuan Deng, Wei-Qing Deng, Shu-Ran Fan, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 240
m6A-binding proteins: the emerging crucial performers in epigenetics
Yanchun Zhao, Yuanfei Shi, Huafei Shen, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 233
Role of m6A RNA methylation in cardiovascular disease (Review)
Yuhan Qin, Linqing Li, Erfei Luo, et al.
International Journal of Molecular Medicine (2020) Vol. 46, Iss. 6, pp. 1958-1972
Open Access | Times Cited: 215
N6-methyladenosine modification regulates ferroptosis through autophagy signaling pathway in hepatic stellate cells
Min Shen, Yujia Li, Yingqian Wang, et al.
Redox Biology (2021) Vol. 47, pp. 102151-102151
Open Access | Times Cited: 167
The circular RNA circ-ERBIN promotes growth and metastasis of colorectal cancer by miR-125a-5p and miR-138-5p/4EBP-1 mediated cap-independent HIF-1α translation
Liangyan Chen, Lian Wang, Yue-Xiang Ren, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 147
Targeting the RNA m6A modification for cancer immunotherapy
Xinxin Li, Shoubao Ma, Youcai Deng, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 139
Surmounting cancer drug resistance: New insights from the perspective of N6-methyladenosine RNA modification
Bowen Li, Jingwen Jiang, Yehuda G. Assaraf, et al.
Drug Resistance Updates (2020) Vol. 53, pp. 100720-100720
Closed Access | Times Cited: 136
Role of m6A writers, erasers and readers in cancer
Zhen Fang, Wentong Mei, Chang Qu, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 131
YTHDF1 promotes breast cancer progression by facilitating FOXM1 translation in an m6A-dependent manner
Hengyu Chen, Yuanhang Yu, Ming Yang, et al.
Cell & Bioscience (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 75
RNA-binding proteins in regulating mRNA stability and translation: roles and mechanisms in cancer
Wei Li, Xiaolan Deng, Jianjun Chen
Seminars in Cancer Biology (2022) Vol. 86, pp. 664-677
Open Access | Times Cited: 73
The essential roles of m6A RNA modification to stimulate ENO1-dependent glycolysis and tumorigenesis in lung adenocarcinoma
Lifang Ma, Xiangfei Xue, Xiao Zhang, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 68
The structure and function of YTHDF epitranscriptomic m6A readers
Vilbert Sikorski, Simona Selberg, Maciej Łałowski, et al.
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 6, pp. 335-353
Open Access | Times Cited: 49
N6-methyladenosine reader YTHDF family in biological processes: Structures, roles, and mechanisms
Lin Chen, Yang Gao, Simiao Xu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 43
The role of RNA methylation in tumor immunity and its potential in immunotherapy
Yan Li, Haoer Jin, Qingling Li, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 17
Molecular characterization, biological function, tumor microenvironment association and clinical significance of m6A regulators in lung adenocarcinoma
Yin Li, Jie Gu, Fengkai Xu, et al.
Briefings in Bioinformatics (2020) Vol. 22, Iss. 4
Closed Access | Times Cited: 126
The m6A readers YTHDF1 and YTHDF3 aberrations associated with metastasis and predict poor prognosis in breast cancer patients.
Anita Ramesh, Paramasivam Arumugam, Vijayashree Priyadharsini Jayaseelan, et al.
PubMed (2020) Vol. 10, Iss. 8, pp. 2546-2554
Closed Access | Times Cited: 124
YTHDC1 mitigates ischemic stroke by promoting Akt phosphorylation through destabilizing PTEN mRNA
Zhaolong Zhang, Qiuhan Wang, Xiaolong Zhao, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 11
Open Access | Times Cited: 97
Targeting YTHDF1 effectively re-sensitizes cisplatin-resistant colon cancer cells by modulating GLS-mediated glutamine metabolism
Ping Chen, Xi-qiao Liu, Xiang Lin, et al.
Molecular Therapy — Oncolytics (2021) Vol. 20, pp. 228-239
Open Access | Times Cited: 97
RNA m6A Modification in Cancers: Molecular Mechanisms and Potential Clinical Applications
Chang Gu, Xin Shi, Chenyang Dai, et al.
The Innovation (2020) Vol. 1, Iss. 3, pp. 100066-100066
Open Access | Times Cited: 94
Page 1 - Next Page

Scroll to top